Latest Articles and Analysis

A proposed OMB rule would let political appointees veto or cancel federal research grants, dismantling the peer-review system and targeting the disparate-impact analysis that maps where HIV concentrates and why. For people living with HIV, that research is the foundation of Ending the HIV Epidemic. The comment period closes July 13.

On March 6, 2026, the Iowa Department of Health and Human Services filed a nine-page complaint in Polk County District Court alleging that NuCara Specialty Pharmacy failed to remit more than $22...

For a long time, I thought advocacy meant surviving the next appointment. I thought it meant learning how to explain my pain better, how to prepare for another referral visit, how to justify why I...

Editor's Note: This article was originally published on April 10, 2026, by Lupus Colorado and is republished here with permission. The Patient Affordability Roundtable discussed in this piece was...

Public health programs like 340B are designed with a clear and urgent purpose: to improve community health, expand access to care, and protect the most vulnerable among us. Whether it’s ensuring...

New Phase 3 data show a single-tablet regimen of bictegravir/lenacapavir could finally bring one-pill simplicity to long-term HIV survivors locked into complex regimens by decades of drug resistance. The science is closing the treatment gap. Will our policy systems do the same?

States are rationing HIV medications through prior auth and formulary cuts to solve ADAP budget crises — a strategy that costs more, drives resistance, and concentrates harm on the most vulnerable.

Rising employer premiums averaging 9.5% erode wages, forcing workers to delay care.

Break Up Big Medicine Act would force structural separation of insurers, PBMs, and pharmacies.

Medicare drug negotiation's third wave includes Biktarvy, raising HIV treatment access concerns.

Q1 2026 Watch: HCV/HIV co-infection treatment access under evolving federal and state policies.

340B program drifted from patient benefit; federal reform needed for transparency and accountability.

Enhanced ACA subsidies expired Jan 1; Senate framework proposes two-year extension with restrictions.

CANN marks 30th anniversary with expanded partnerships and cross-condition advocacy evolution.

2025 healthcare crises result from policy choices as ACA subsidies expire, HIV care deteriorates, and state pricing experiments proliferate.

Senate HELP Committee hearing reveals how 340B drug program expansion reflects hospital business strategy rather than patient benefit.

Q4 2025 Watch monitoring HCV treatment access and federal initiatives including Cure Hepatitis C Act.

Clade I mpox emergence reveals structural collapse in U.S. disease surveillance and public health response infrastructure.

Miss Major Griffin-Gracy's legacy demonstrates solidarity's power in building healthcare justice and community leadership.

Government shutdown disrupts grant payments to community health centers and crisis service providers, threatening vulnerable population access.